STOCK ALARM
PRO
SA
PRO
Market
Screener
Charts
Alerts
⌘
K
LON
NYC
Crypto
Pro
Sign In
Free Account
Ligand Pharmaceuticals Incorporated
LGND
NASDAQ
LOADING
|
|
|
Overview
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
As of
2024
• vs 2023
Annual
Quarterly
Per Share
Revenue/Share
$9.14
+20.4%
Net Income/Share
$-0.22
-107.3%
Operating CF/Share
$5.31
+85.1%
Free CF/Share
$4.23
+1813.7%
Cash/Share
$14.01
+42.3%
Book Value/Share
$45.40
+12.1%
Tangible Book/Share
$25.07
+45.6%
Equity/Share
$45.40
+12.1%
Interest Debt/Share
$0.55
+40.6%
Valuation
Market Cap
$1.96B
+58.6%
Enterprise Value
$1.89B
+55.5%
P/E Ratio
-486.05
-2151.9%
P/S Ratio
11.73
+24.6%
P/OCF Ratio
20.19
-19.0%
P/FCF Ratio
25.32
+108.8%
P/B Ratio
2.36
+33.9%
P/TB Ratio
2.36
+33.9%
EV/Sales
11.34
+22.1%
EV/EBITDA
46.44
+284.3%
Profitability
Earnings Yield
-0.21%
-104.9%
FCF Yield
3.95%
+1242.2%
ROE
-0.49%
-106.5%
ROIC
4.00%
+205.1%
Return on Tangible Assets
-0.71%
-105.2%
Capital Allocation
CapEx/OCF
20.24%
-81.4%
CapEx/Revenue
11.75%
-71.3%
CapEx/Depreciation
0.56
-62.2%
SBC/Revenue
24.58%
+25.4%
Balance Sheet
Debt/Equity
0.01
-2.7%
Debt/Assets
0.01
-3.7%
Net Debt/EBITDA
-1.60
-860.0%
Current Ratio
8.93
-36.9%
Interest Coverage
-7.44x
-140.9%
Income Quality
-24.07
-2632.0%
Efficiency
Days Sales Outstanding
93 days
-15.2%
Days Payables Outstanding
172 days
+582.4%
Days Inventory
465 days
+86.4%
Receivables Turnover
3.94x
+17.9%
Payables Turnover
2.12x
-85.3%
Inventory Turnover
0.78x
-46.3%
Special Valuations
Graham Number
--
Graham Net-Net
$10.05
+38.5%